113 related articles for article (PubMed ID: 33667422)
1. Molecular analysis of encapsulated papillary carcinoma of the breast with and without invasion.
Schwartz CJ; Boroujeni AM; Khodadadi-Jamayran A; Heguy A; Snuderl M; Jour G; Cotzia P; Darvishian F
Hum Pathol; 2021 May; 111():67-74. PubMed ID: 33667422
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotypic and genomic characterization of papillary carcinomas of the breast.
Duprez R; Wilkerson PM; Lacroix-Triki M; Lambros MB; MacKay A; A'Hern R; Gauthier A; Pawar V; Colombo PE; Daley F; Natrajan R; Ward E; MacGrogan G; Arbion F; Michenet P; Weigelt B; Vincent-Salomon A; Reis-Filho JS
J Pathol; 2012 Feb; 226(3):427-441. PubMed ID: 22025283
[TBL] [Abstract][Full Text] [Related]
3. Solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms (solid papillary carcinomas with reverse polarity) harbour recurrent mutations affecting IDH2 and PIK3CA: a validation cohort.
Lozada JR; Basili T; Pareja F; Alemar B; Paula ADC; Gularte-Merida R; Giri DD; Querzoli P; Cserni G; Rakha EA; Foschini MP; Reis-Filho JS; Brogi E; Weigelt B; Geyer FC
Histopathology; 2018 Aug; 73(2):339-344. PubMed ID: 29603332
[TBL] [Abstract][Full Text] [Related]
4. Solid Papillary Carcinoma and Encapsulated Papillary Carcinoma of the Breast: Clinical-Pathologic Features and Basement Membrane Studies of 50 Cases.
Morgan S; Dodington D; Wu JM; Turashvili G
Pathobiology; 2021; 88(5):359-373. PubMed ID: 34265775
[TBL] [Abstract][Full Text] [Related]
5. Are encapsulated papillary carcinomas of the breast in situ or invasive? A basement membrane study of 27 cases.
Esposito NN; Dabbs DJ; Bhargava R
Am J Clin Pathol; 2009 Feb; 131(2):228-42. PubMed ID: 19141383
[TBL] [Abstract][Full Text] [Related]
6. PIK3CA mutations in ductal carcinoma in situ and adjacent invasive breast cancer.
Agahozo MC; Sieuwerts AM; Doebar SC; Verhoef EI; Beaufort CM; Ruigrok-Ritstier K; de Weerd V; Sleddens HFBM; Dinjens WNM; Martens JWM; van Deurzen CHM
Endocr Relat Cancer; 2019 May; 26(5):471-482. PubMed ID: 30844755
[TBL] [Abstract][Full Text] [Related]
7. PIK3CA-AKT pathway mutations in micropapillary breast carcinoma.
Flatley E; Ang D; Warrick A; Beadling C; Corless CL; Troxell ML
Hum Pathol; 2013 Jul; 44(7):1320-7. PubMed ID: 23352210
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast.
Troxell ML; Levine J; Beadling C; Warrick A; Dunlap J; Presnell A; Patterson J; Shukla A; Olson NR; Heinrich MC; Corless CL
Mod Pathol; 2010 Jan; 23(1):27-37. PubMed ID: 19898424
[TBL] [Abstract][Full Text] [Related]
9. Intracystic papillary carcinoma of breast: interrelationship with in situ and invasive carcinoma and a proposal of pathogenesis: array comparative genomic hybridization study of 14 cases.
Khoury T; Hu Q; Liu S; Wang J
Mod Pathol; 2014 Feb; 27(2):194-203. PubMed ID: 23907150
[TBL] [Abstract][Full Text] [Related]
10. Mucinous breast carcinomas lack PIK3CA and AKT1 mutations.
Kehr EL; Jorns JM; Ang D; Warrick A; Neff T; Degnin M; Lewis R; Beadling C; Corless CL; Troxell ML
Hum Pathol; 2012 Dec; 43(12):2207-12. PubMed ID: 22705004
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity.
Pareja F; da Silva EM; Frosina D; Geyer FC; Lozada JR; Basili T; Da Cruz Paula A; Zhong E; Derakhshan F; D'Alfonso T; Wen HY; Giri DD; Hayes MM; Krings G; Bhargava R; Palazzo JP; Rakha EA; Hoda SA; Sanders ME; Collins LC; Schnitt SJ; Chen YY; Weigelt B; Jungbluth AA; Reis-Filho JS; Brogi E
Mod Pathol; 2020 Jun; 33(6):1056-1064. PubMed ID: 31896809
[TBL] [Abstract][Full Text] [Related]
12. Solid papillary carcinoma with reverse polarity of the breast harbors specific morphologic, immunohistochemical and molecular profile in comparison with other benign or malignant papillary lesions of the breast: a comparative study of 9 additional cases.
Alsadoun N; MacGrogan G; Truntzer C; Lacroix-Triki M; Bedgedjian I; Koeb MH; El Alam E; Medioni D; Parent M; Wuithier P; Robert I; Boidot R; Arnould L
Mod Pathol; 2018 Sep; 31(9):1367-1380. PubMed ID: 29785016
[TBL] [Abstract][Full Text] [Related]
13. Polarity gene alterations in pure invasive micropapillary carcinomas of the breast.
Gruel N; Benhamo V; Bhalshankar J; Popova T; Fréneaux P; Arnould L; Mariani O; Stern MH; Raynal V; Sastre-Garau X; Rouzier R; Delattre O; Vincent-Salomon A
Breast Cancer Res; 2014 May; 16(3):R46. PubMed ID: 24887297
[TBL] [Abstract][Full Text] [Related]
14. Adenomyoepitheliomas of the Breast Frequently Harbor Recurrent Hotspot Mutations in PIK3-AKT Pathway-related Genes and a Subset Show Genetic Similarity to Salivary Gland Epithelial-Myoepithelial Carcinoma.
Lubin D; Toorens E; Zhang PJ; Jaffer S; Baraban E; Bleiweiss IJ; Nayak A
Am J Surg Pathol; 2019 Jul; 43(7):1005-1013. PubMed ID: 31094929
[TBL] [Abstract][Full Text] [Related]
15. PIK3CA Mutational Status Is Associated with High Glycolytic Activity in ER+/HER2- Early Invasive Breast Cancer: a Molecular Imaging Study Using [
Magometschnigg H; Pinker K; Helbich T; Brandstetter A; Rudas M; Nakuz T; Baltzer P; Wadsak W; Hacker M; Weber M; Dubsky P; Filipits M
Mol Imaging Biol; 2019 Oct; 21(5):991-1002. PubMed ID: 30652258
[TBL] [Abstract][Full Text] [Related]
16. Encapsulated papillary carcinoma of the breast: An institutional case series and literature review.
Tan HJ; Tan PH; Leong LCH; Tan VKM; Tan BKT; Lim SZ; Preetha M; Wong CY; Yong WS; Sim Y
Cancer Med; 2023 May; 12(10):11408-11416. PubMed ID: 36999966
[TBL] [Abstract][Full Text] [Related]
17. Encapsulated papillary carcinoma of the breast: A clinicopathological study of 49 cases.
Li X; Xu Y; Ye H; Qin S; Hou F; Liu W
Curr Probl Cancer; 2018; 42(3):291-301. PubMed ID: 29731165
[TBL] [Abstract][Full Text] [Related]
18. IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity.
Chiang S; Weigelt B; Wen HC; Pareja F; Raghavendra A; Martelotto LG; Burke KA; Basili T; Li A; Geyer FC; Piscuoglio S; Ng CK; Jungbluth AA; Balss J; Pusch S; Baker GM; Cole KS; von Deimling A; Batten JM; Marotti JD; Soh HC; McCalip BL; Serrano J; Lim RS; Siziopikou KP; Lu S; Liu X; Hammour T; Brogi E; Snuderl M; Iafrate AJ; Reis-Filho JS; Schnitt SJ
Cancer Res; 2016 Dec; 76(24):7118-7129. PubMed ID: 27913435
[TBL] [Abstract][Full Text] [Related]
19. Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers.
Collins LC; Carlo VP; Hwang H; Barry TS; Gown AM; Schnitt SJ
Am J Surg Pathol; 2006 Aug; 30(8):1002-7. PubMed ID: 16861972
[TBL] [Abstract][Full Text] [Related]
20. Encapsulated papillary carcinoma of the breast: a study of invasion associated markers.
Rakha EA; Tun M; Junainah E; Ellis IO; Green A
J Clin Pathol; 2012 Aug; 65(8):710-4. PubMed ID: 22554960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
